Cost-Effectiveness Analysis of Chemoradiation and Radiotherapy Treatment for Stage IIB and IIIB Cervical Cancer Patients

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Center of Data and Information Ministry of Health Republic of Indonesia. Stop cancer; 2015. Available from: https://www.kemkes.go.id/folder/view/01/structure-publikasi-pusdatin-info-datin.html. Accessed July 8, 2020.
   Google Scholar
• Cetina L, Rivera L, Hinojosa J, et al. Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results. BMC Womens Health. 2006;6:3. doi:10.1186/1472-6874-6-3
   PubMedGoogle Scholar
• Azad SK, Choudhary V. Treatment results of radical radiotherapy of carcinoma uterine cervix using external beam radiotherapy and high dose rate intracavitary radiotherapy. J Cancer Res Ther. 2010;6(4):482–486. doi:10.4103/0973-1482.77108
   Web of Science ®Google Scholar
• National Cancer Institute. Cervical cancer treatment (PDQ®)–health professional version. Available from: https://www.cancer.gov/types/cervical/hp/cervical-treatment-pdq. Accessed April 30, 2018.
   Google Scholar
• American Cancer Society. Treatment options for cervical cancer, by stage. Available from: https://www.cancer.org/cancer/cervical-cancer/treating/by-stage.html. Accessed July 8, 2020.
   Google Scholar
• Ministry of Health Republic of Indonesia. National Guidelines for Cervical Cancer Medical Services; 2017.
   Google Scholar
• Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet (London, England). 2001;358(9284):781–786. doi:10.1016/S0140-6736(01)05965-7
   PubMed Web of Science ®Google Scholar
• Choi IJ, Cha MS, Park ES, et al. The efficacy of concurrent cisplatin and 5-flurouracil chemotherapy and radiation therapy for locally advanced cancer of the uterine cervix. J Gynecol Oncol. 2008;19(2):129–134. doi:10.3802/jgo.2008.19.2.129
   PubMedGoogle Scholar
• Li Z, Yang S, Liu L, Han S. A comparison of concurrent chemoradiotherapy and radiotherapy in Chinese patients with locally advanced cervical carcinoma: a multi-center study. Radiat Oncol. 2014;9:212. doi:10.1186/1748-717X-9-212
   PubMed Web of Science ®Google Scholar
• Manusirivithaya S, Sripramote M, Tangjitgamol S, Sanjareonsuttikul N, Pisarnturakit P. Cost effectiveness of concurrent chemoradiation in comparison with radiation alone in locally advanced cervical cancer. J Med Assoc Thai. 2005;88(8):1035–1044.
   Google Scholar
• Subramanian S, Trogdon J, Ekwueme DU, Gardner JG, Whitmire JT, Rao C. Cost of cervical cancer treatment: implications for providing coverage to low-income women under the Medicaid expansion for cancer care. Womens Health Issues. 2010;20(6):400–405. doi:10.1016/j.whi.2010.07.002
   PubMed Web of Science ®Google Scholar
• Audriene D Ministry of health: cancer treatment costs in 2017. 2018. Available from: https://www.cnnindonesia.com/gaya-hidup/20180407180941-255-289105/kemenkes-biaya-pengobatan-kanker-di-2017-hampir-rp3-triliun. Accessed April 7, 2018.
   Google Scholar
• Pendrith C, Thind A, Zaric GS, Sarma S. Costs of cervical cancer treatment: population-based estimates from Ontario. Curr Oncol. 2016;23(2):e109–e115. doi:10.3747/co.23.2598
   Web of Science ®Google Scholar
• Legianawati D, Puspitasari IM, Suwantika AA, Kusumadjati A. Management profile of stage IIB–IIIB cervical cancer with radiation therapy and chemoradiation at Dr. Hasan Sadikin General Hospital Bandung in 2015–2017. Indones J Clin Pharm. 2019;8(3):205–216.
   Google Scholar
• Central Statistics Agency of Indonesia. Monthly indonesia consumers price indices and inflations. Available from: https://www.bps.go.id/statictable/2009/06/15/907/indeks-harga-konsumen-dan-inflasi-bulanan-indonesia-2006-2020.html. Accessed July 8, 2020.
   Google Scholar
• World Health Organization. WHO handbook for reporting results of cancer treatment; 1979. Available from: https://apps.who.int/iris/handle/10665/37200. Accessed February 9, 2021.
   Google Scholar
• Ministry of Health Republic of Indonesia. Guideline for Applying Pharmacoeconimics Study; 2013.
   Google Scholar
• Jain R, Grabner M, Onukwugha E. Sensitivity analysis in cost-effectiveness studies: from guidelines to practice. Pharmacoeconomics. 2011;29(4):297–314. doi:10.2165/11584630-000000000-00000
   PubMed Web of Science ®Google Scholar
• Kim H, Rajagopalan MS, Beriwal S, Huq MS, Smith KJ. Cost-effectiveness analysis of 3D image-guided brachytherapy compared with 2D brachytherapy in the treatment of locally advanced cervical cancer. Brachytherapy. 2015;14(1):29–36. doi:10.1016/j.brachy.2014.09.002
   Web of Science ®Google Scholar
• Kashyap N, Krishnan N, Kaur S, Ghai S. Risk factors of cervical cancer: a case-control study. Asia-Pac J Oncol Nurs. 2019;6(3):308–314. doi:10.4103/apjon.apjon_73_18
   PubMed Web of Science ®Google Scholar
• Franceschi S, Plummer M, Clifford G, et al. Differences in the risk of cervical cancer and human papillomavirus infection by education level. Br J Cancer. 2009;101(5):865–870. doi:10.1038/sj.bjc.6605224
   PubMed Web of Science ®Google Scholar
• Segni MT, Demissie HF, Tadesse DM, Amdemichael R, Mamo YT, Worku A. Level of knowledge and associated factor toward cervical cancer among women age (21–64) years visiting health facilities in Gulele Sub-city Addis Ababa Ethiopia. J Pancreas. 2017;18(1):44–48.
   Web of Science ®Google Scholar
• Reis N. Risk factors for cervical cancer: results from a hospital-based case-control study. Int J Hematol Oncol. 2011;21:153–159. doi:10.4999/uhod.09061
   Google Scholar
• Dwipoyono B, Nasdaldy SS, Adisasmita A. Histologic type and age in uteric cervical cancer at Dharmais Cancer Hospital. Indones J Cancer. 2007;1(1):7–11. doi:10.33371/ijoc.v1i1.1
   Google Scholar
• Watulingas AM, Loho M, Wagey F. Characteristics of cervical cancer patients at RSUP Prof. Dr. R. D. Kandou Manado for the period of 1 January 2013-31 December 2015. J e-Clinic. 2016;4(2):1–5. doi:10.35790/ecl.4.2.2016.14477
   Google Scholar
• Basta T, Knapp P, Blecharz P, et al. Current management of cervical cancer in Poland-Analysis of the questionnaire trial for the years 2002–2014 in relation to ASCO 2016 recommendations. PLoS One. 2019;14(1):e0209901. doi:10.1371/journal.pone.0209901
   Web of Science ®Google Scholar